The selective glucocorticoid receptor modulator CORT108297 restores faulty hippocampal parameters in Wobbler and corticosterone-treated mice

Mutant Wobbler mice are models for human amyotrophic lateral sclerosis (ALS). In addition to spinal cord degeneration, Wobbler mice show high levels of blood corticosterone, hyperactivity of the hypothalamic-pituitary-adrenal axis and abnormalities of the hippocampus. Hypersecretion of glucocorticoi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Meyer, M., Gonzalez Deniselle, M.C., Hunt, H., Kloet, E.R.D., De Nicola, A.F.
Formato: JOUR
Materias:
Acceso en línea:http://hdl.handle.net/20.500.12110/paper_09600760_v143_n_p40_Meyer
Aporte de:
id todo:paper_09600760_v143_n_p40_Meyer
record_format dspace
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Astrogliosis
CORT108297
Corticosterone
Glucocorticoid receptor antagonist
Hippocampus
Microglia
Neurogenesis
Wobbler mice
binding protein
brain protein
cort 108297
cort108297
corticosterone
doublecortin
glial fibrillary acidic protein
glucocorticoid receptor
ionized calcium binding adapter molecule 1
neuron specific nuclear protein
recombinant hormone
unclassified drug
antiinflammatory agent
CORT 108297
corticosterone
doublecortin protein
fused heterocyclic rings
glial fibrillary acidic protein
glucocorticoid receptor
heterocyclic compound
microtubule associated protein
nerve protein
NeuN protein, mouse
neuropeptide
nuclear protein
adrenal cortex disease
animal experiment
animal model
article
astrocyte
astrocyte hypertrophy
astrocytosis
cell activity
cell count
cell function
controlled study
corticosterone blood level
dentate gyrus
doublecortin+ neuroblast
drug brain level
drug effect
drug mechanism
drug receptor binding
drug response
glial fibrillary acidic protein+astrocyte
hippocampus
hypercorticosteronemia
hypertrophy
ionized calcium binding adapter molecule 1+microglia
microglia
mouse
nervous system parameters
neuroblast
neuron specific nuclear protein+ cell
nonhuman
phenotype
treatment duration
animal
antagonists and inhibitors
cell culture
comparative study
cytology
disease model
drug effects
enzyme immunoassay
female
fluorescent antibody technique
hippocampus
human
metabolism
mouse mutant
nerve cell
physiology
Western blotting
Animals
Anti-Inflammatory Agents
Astrocytes
Aza Compounds
Blotting, Western
Cells, Cultured
Corticosterone
Disease Models, Animal
Female
Fluorescent Antibody Technique
Glial Fibrillary Acidic Protein
Heterocyclic Compounds with 4 or More Rings
Hippocampus
Humans
Immunoenzyme Techniques
Mice
Mice, Neurologic Mutants
Microglia
Microtubule-Associated Proteins
Nerve Tissue Proteins
Neurons
Neuropeptides
Nuclear Proteins
Receptors, Glucocorticoid
spellingShingle Astrogliosis
CORT108297
Corticosterone
Glucocorticoid receptor antagonist
Hippocampus
Microglia
Neurogenesis
Wobbler mice
binding protein
brain protein
cort 108297
cort108297
corticosterone
doublecortin
glial fibrillary acidic protein
glucocorticoid receptor
ionized calcium binding adapter molecule 1
neuron specific nuclear protein
recombinant hormone
unclassified drug
antiinflammatory agent
CORT 108297
corticosterone
doublecortin protein
fused heterocyclic rings
glial fibrillary acidic protein
glucocorticoid receptor
heterocyclic compound
microtubule associated protein
nerve protein
NeuN protein, mouse
neuropeptide
nuclear protein
adrenal cortex disease
animal experiment
animal model
article
astrocyte
astrocyte hypertrophy
astrocytosis
cell activity
cell count
cell function
controlled study
corticosterone blood level
dentate gyrus
doublecortin+ neuroblast
drug brain level
drug effect
drug mechanism
drug receptor binding
drug response
glial fibrillary acidic protein+astrocyte
hippocampus
hypercorticosteronemia
hypertrophy
ionized calcium binding adapter molecule 1+microglia
microglia
mouse
nervous system parameters
neuroblast
neuron specific nuclear protein+ cell
nonhuman
phenotype
treatment duration
animal
antagonists and inhibitors
cell culture
comparative study
cytology
disease model
drug effects
enzyme immunoassay
female
fluorescent antibody technique
hippocampus
human
metabolism
mouse mutant
nerve cell
physiology
Western blotting
Animals
Anti-Inflammatory Agents
Astrocytes
Aza Compounds
Blotting, Western
Cells, Cultured
Corticosterone
Disease Models, Animal
Female
Fluorescent Antibody Technique
Glial Fibrillary Acidic Protein
Heterocyclic Compounds with 4 or More Rings
Hippocampus
Humans
Immunoenzyme Techniques
Mice
Mice, Neurologic Mutants
Microglia
Microtubule-Associated Proteins
Nerve Tissue Proteins
Neurons
Neuropeptides
Nuclear Proteins
Receptors, Glucocorticoid
Meyer, M.
Gonzalez Deniselle, M.C.
Hunt, H.
Kloet, E.R.D.
De Nicola, A.F.
The selective glucocorticoid receptor modulator CORT108297 restores faulty hippocampal parameters in Wobbler and corticosterone-treated mice
topic_facet Astrogliosis
CORT108297
Corticosterone
Glucocorticoid receptor antagonist
Hippocampus
Microglia
Neurogenesis
Wobbler mice
binding protein
brain protein
cort 108297
cort108297
corticosterone
doublecortin
glial fibrillary acidic protein
glucocorticoid receptor
ionized calcium binding adapter molecule 1
neuron specific nuclear protein
recombinant hormone
unclassified drug
antiinflammatory agent
CORT 108297
corticosterone
doublecortin protein
fused heterocyclic rings
glial fibrillary acidic protein
glucocorticoid receptor
heterocyclic compound
microtubule associated protein
nerve protein
NeuN protein, mouse
neuropeptide
nuclear protein
adrenal cortex disease
animal experiment
animal model
article
astrocyte
astrocyte hypertrophy
astrocytosis
cell activity
cell count
cell function
controlled study
corticosterone blood level
dentate gyrus
doublecortin+ neuroblast
drug brain level
drug effect
drug mechanism
drug receptor binding
drug response
glial fibrillary acidic protein+astrocyte
hippocampus
hypercorticosteronemia
hypertrophy
ionized calcium binding adapter molecule 1+microglia
microglia
mouse
nervous system parameters
neuroblast
neuron specific nuclear protein+ cell
nonhuman
phenotype
treatment duration
animal
antagonists and inhibitors
cell culture
comparative study
cytology
disease model
drug effects
enzyme immunoassay
female
fluorescent antibody technique
hippocampus
human
metabolism
mouse mutant
nerve cell
physiology
Western blotting
Animals
Anti-Inflammatory Agents
Astrocytes
Aza Compounds
Blotting, Western
Cells, Cultured
Corticosterone
Disease Models, Animal
Female
Fluorescent Antibody Technique
Glial Fibrillary Acidic Protein
Heterocyclic Compounds with 4 or More Rings
Hippocampus
Humans
Immunoenzyme Techniques
Mice
Mice, Neurologic Mutants
Microglia
Microtubule-Associated Proteins
Nerve Tissue Proteins
Neurons
Neuropeptides
Nuclear Proteins
Receptors, Glucocorticoid
description Mutant Wobbler mice are models for human amyotrophic lateral sclerosis (ALS). In addition to spinal cord degeneration, Wobbler mice show high levels of blood corticosterone, hyperactivity of the hypothalamic-pituitary-adrenal axis and abnormalities of the hippocampus. Hypersecretion of glucocorticoids increase hippocampus vulnerability, a process linked to an enriched content of glucocorticoid receptors (GR). Hence, we studied if a selective GR antagonist (CORT108297) with null affinity for other steroid receptors restored faulty hippocampus parameters of Wobbler mice. Three months old genotyped Wobbler mice received s.c. vehicle or CORT108297 during 4 days. We compared the response of doublecortin (DCX)+ neuroblasts in the subgranular layer of the dentate gyrus (DG), NeuN+ cells in the hilus of the DG, glial fibrillary acidic protein (GFAP)+ astrocytes and the phenotype of Iba1+ microglia in CORT108297-treated and vehicle-treated Wobblers. The number of DCX+ cells in Wobblers was lower than in control mice, whereas CORT108297 restored this parameter. After CORT108297 treatment, Wobblers showed diminished astrogliosis, and changed the phenotype of Iba1+ microglia from an activated to a quiescent form. These changes occurred without alterations in the hypercorticosteronemia or the number of NeuN+ cells of the Wobblers. In a separate experiment employing control NFR/NFR mice, treatment with corticosterone for 5 days reduced DCX+ neuroblasts and induced astrocyte hypertrophy, whereas treatment with CORT108297 antagonized these effects. Normalization of neuronal progenitors, astrogliosis and microglial phenotype by CORT108297 indicates the usefulness of this antagonist to normalize hippocampus parameters of Wobbler mice. Thus, CORT108297 opens new therapeutic options for the brain abnormalities of ALS patients and hyperadrenocorticisms. © 2014 Elsevier Ltd.
format JOUR
author Meyer, M.
Gonzalez Deniselle, M.C.
Hunt, H.
Kloet, E.R.D.
De Nicola, A.F.
author_facet Meyer, M.
Gonzalez Deniselle, M.C.
Hunt, H.
Kloet, E.R.D.
De Nicola, A.F.
author_sort Meyer, M.
title The selective glucocorticoid receptor modulator CORT108297 restores faulty hippocampal parameters in Wobbler and corticosterone-treated mice
title_short The selective glucocorticoid receptor modulator CORT108297 restores faulty hippocampal parameters in Wobbler and corticosterone-treated mice
title_full The selective glucocorticoid receptor modulator CORT108297 restores faulty hippocampal parameters in Wobbler and corticosterone-treated mice
title_fullStr The selective glucocorticoid receptor modulator CORT108297 restores faulty hippocampal parameters in Wobbler and corticosterone-treated mice
title_full_unstemmed The selective glucocorticoid receptor modulator CORT108297 restores faulty hippocampal parameters in Wobbler and corticosterone-treated mice
title_sort selective glucocorticoid receptor modulator cort108297 restores faulty hippocampal parameters in wobbler and corticosterone-treated mice
url http://hdl.handle.net/20.500.12110/paper_09600760_v143_n_p40_Meyer
work_keys_str_mv AT meyerm theselectiveglucocorticoidreceptormodulatorcort108297restoresfaultyhippocampalparametersinwobblerandcorticosteronetreatedmice
AT gonzalezdenisellemc theselectiveglucocorticoidreceptormodulatorcort108297restoresfaultyhippocampalparametersinwobblerandcorticosteronetreatedmice
AT hunth theselectiveglucocorticoidreceptormodulatorcort108297restoresfaultyhippocampalparametersinwobblerandcorticosteronetreatedmice
AT kloeterd theselectiveglucocorticoidreceptormodulatorcort108297restoresfaultyhippocampalparametersinwobblerandcorticosteronetreatedmice
AT denicolaaf theselectiveglucocorticoidreceptormodulatorcort108297restoresfaultyhippocampalparametersinwobblerandcorticosteronetreatedmice
AT meyerm selectiveglucocorticoidreceptormodulatorcort108297restoresfaultyhippocampalparametersinwobblerandcorticosteronetreatedmice
AT gonzalezdenisellemc selectiveglucocorticoidreceptormodulatorcort108297restoresfaultyhippocampalparametersinwobblerandcorticosteronetreatedmice
AT hunth selectiveglucocorticoidreceptormodulatorcort108297restoresfaultyhippocampalparametersinwobblerandcorticosteronetreatedmice
AT kloeterd selectiveglucocorticoidreceptormodulatorcort108297restoresfaultyhippocampalparametersinwobblerandcorticosteronetreatedmice
AT denicolaaf selectiveglucocorticoidreceptormodulatorcort108297restoresfaultyhippocampalparametersinwobblerandcorticosteronetreatedmice
_version_ 1807316783986638848
spelling todo:paper_09600760_v143_n_p40_Meyer2023-10-03T15:53:23Z The selective glucocorticoid receptor modulator CORT108297 restores faulty hippocampal parameters in Wobbler and corticosterone-treated mice Meyer, M. Gonzalez Deniselle, M.C. Hunt, H. Kloet, E.R.D. De Nicola, A.F. Astrogliosis CORT108297 Corticosterone Glucocorticoid receptor antagonist Hippocampus Microglia Neurogenesis Wobbler mice binding protein brain protein cort 108297 cort108297 corticosterone doublecortin glial fibrillary acidic protein glucocorticoid receptor ionized calcium binding adapter molecule 1 neuron specific nuclear protein recombinant hormone unclassified drug antiinflammatory agent CORT 108297 corticosterone doublecortin protein fused heterocyclic rings glial fibrillary acidic protein glucocorticoid receptor heterocyclic compound microtubule associated protein nerve protein NeuN protein, mouse neuropeptide nuclear protein adrenal cortex disease animal experiment animal model article astrocyte astrocyte hypertrophy astrocytosis cell activity cell count cell function controlled study corticosterone blood level dentate gyrus doublecortin+ neuroblast drug brain level drug effect drug mechanism drug receptor binding drug response glial fibrillary acidic protein+astrocyte hippocampus hypercorticosteronemia hypertrophy ionized calcium binding adapter molecule 1+microglia microglia mouse nervous system parameters neuroblast neuron specific nuclear protein+ cell nonhuman phenotype treatment duration animal antagonists and inhibitors cell culture comparative study cytology disease model drug effects enzyme immunoassay female fluorescent antibody technique hippocampus human metabolism mouse mutant nerve cell physiology Western blotting Animals Anti-Inflammatory Agents Astrocytes Aza Compounds Blotting, Western Cells, Cultured Corticosterone Disease Models, Animal Female Fluorescent Antibody Technique Glial Fibrillary Acidic Protein Heterocyclic Compounds with 4 or More Rings Hippocampus Humans Immunoenzyme Techniques Mice Mice, Neurologic Mutants Microglia Microtubule-Associated Proteins Nerve Tissue Proteins Neurons Neuropeptides Nuclear Proteins Receptors, Glucocorticoid Mutant Wobbler mice are models for human amyotrophic lateral sclerosis (ALS). In addition to spinal cord degeneration, Wobbler mice show high levels of blood corticosterone, hyperactivity of the hypothalamic-pituitary-adrenal axis and abnormalities of the hippocampus. Hypersecretion of glucocorticoids increase hippocampus vulnerability, a process linked to an enriched content of glucocorticoid receptors (GR). Hence, we studied if a selective GR antagonist (CORT108297) with null affinity for other steroid receptors restored faulty hippocampus parameters of Wobbler mice. Three months old genotyped Wobbler mice received s.c. vehicle or CORT108297 during 4 days. We compared the response of doublecortin (DCX)+ neuroblasts in the subgranular layer of the dentate gyrus (DG), NeuN+ cells in the hilus of the DG, glial fibrillary acidic protein (GFAP)+ astrocytes and the phenotype of Iba1+ microglia in CORT108297-treated and vehicle-treated Wobblers. The number of DCX+ cells in Wobblers was lower than in control mice, whereas CORT108297 restored this parameter. After CORT108297 treatment, Wobblers showed diminished astrogliosis, and changed the phenotype of Iba1+ microglia from an activated to a quiescent form. These changes occurred without alterations in the hypercorticosteronemia or the number of NeuN+ cells of the Wobblers. In a separate experiment employing control NFR/NFR mice, treatment with corticosterone for 5 days reduced DCX+ neuroblasts and induced astrocyte hypertrophy, whereas treatment with CORT108297 antagonized these effects. Normalization of neuronal progenitors, astrogliosis and microglial phenotype by CORT108297 indicates the usefulness of this antagonist to normalize hippocampus parameters of Wobbler mice. Thus, CORT108297 opens new therapeutic options for the brain abnormalities of ALS patients and hyperadrenocorticisms. © 2014 Elsevier Ltd. JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_09600760_v143_n_p40_Meyer